AlphaCrest Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,383
| Closed | -$1.01M | – | 891 |
|
|
2022
Q3 | $1.01M | Buy |
+24,383
| New | +$1.01M | 0.06% | 608 |
|
|
2022
Q2 | – | Sell |
-7,015
| Closed | -$509K | – | 1350 |
|
|
2022
Q1 | $509K | Buy |
7,015
+3,725
| +113% | +$270K | 0.03% | 888 |
|
|
2021
Q4 | $277K | Sell |
3,290
-3,158
| -49% | -$266K | 0.01% | 1273 |
|
|
2021
Q3 | $582K | Sell |
6,448
-6,353
| -50% | -$573K | 0.03% | 851 |
|
|
2021
Q2 | $1.22M | Buy |
+12,801
| New | +$1.22M | 0.05% | 566 |
|
|
2020
Q4 | – | Sell |
-6,542
| Closed | -$538K | – | 1246 |
|
|
2020
Q3 | $538K | Buy |
6,542
+3,800
| +139% | +$313K | 0.06% | 544 |
|
|
2020
Q2 | $214K | Sell |
2,742
-4,574
| -63% | -$357K | 0.04% | 814 |
|
|
2020
Q1 | $325K | Buy |
+7,316
| New | +$325K | 0.04% | 769 |
|
|
2019
Q3 | – | Sell |
-4,311
| Closed | -$274K | – | 1323 |
|
|
2019
Q2 | $274K | Buy |
+4,311
| New | +$274K | 0.02% | 890 |
|